小智港股覆盤 | 12月22日
今日，港股三大指數集體上漲。截止收盤，恆生指數漲0.57%，報23102點。國企指數漲0.66%，報8195點。恆生科技指數漲1.29%，報5685點。市場約895只個股上漲，749只個股下跌。成交額突破927.82億港幣，和昨天同期相比下跌15.87%。南下資金淨流入30.46億港幣。
盤面上，娛樂板塊漲幅較前。火巖控股漲超52%；稻草熊娛樂漲超6%；嗶哩嗶哩-SW、指尖悅動等多股漲超5%；ITP HOLDINGS漲超4%。火巖控股曾飆67%高見1.42元，控股股東斥163萬元增持；稻草熊娛樂高開逾5%，擬收購上海金禾影視傳播有限公司；嗶哩嗶哩(9626.HK)高開7.14%。
汽車板塊大漲靠前。小鵬汽車-W漲超6%；長城汽車漲超4%；比亞迪股份漲超3%；理想汽車-W漲超2%；雅迪控股漲超1%。中金：明年乘用車生產批發有望保持高增，看好理想汽車-W、小鵬汽車-W等；開源證券首予比亞迪電子“買入”評級，高盛大幅上調長城汽車目標價至31.9港元。
服裝紡織板塊漲幅較前。粵海製革漲超14%；樺欣控股漲超13%；江南布衣漲超10%；慕詩國際、亞東集團等多股漲超9%。
海運板塊跌幅居前。海豐國際、中遠海控、太平洋航運等多股跌超4%；東方海外國際跌超1%。大和微降海豐國際目標價至46元，評級「買入」。
生物科技板塊走弱。信達生物跌超5%；再鼎醫藥-SB跌超4%；雲頂新耀-B、榮昌生物-B、康方生物-B等多股跌超3%。高盛輕微上調再鼎醫藥-SB目標價至1,482.57元，評級「買入」；高盛微升雲頂新耀-Ｂ目標價2.2%至106.63港元，維持“買入”評級；榮昌生物-B：受託人根據首期H股獎勵信託計劃購買10萬股；康方生物就受限制股份單位計劃買入52萬股。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
